Yi Sun

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi SAG/ROC/Rbx/Hrt, a zinc RING finger gene family: molecular cloning, biochemical properties, and biological functions
    Y Sun
    Cancer Molecular Sciences, Pfizer Global Research and Development, Ann Arbor Laboratories, MI 48105, USA
    Antioxid Redox Signal 3:635-50. 2001
  2. ncbi Seeing is believing: visualization of transcriptional activity of p53
    Yi Sun
    Cancer Molecular Sciences, Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48105, USA
    Cancer Biol Ther 2:203-5. 2003
  3. ncbi Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor
    Dongping Wei
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109, USA
    Cancer Res 72:282-93. 2012
  4. ncbi Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases
    Jie Yang
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA
    Mol Cancer Ther 10:658-69. 2011
  5. ncbi Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target
    Lijun Jia
    Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA
    Clin Cancer Res 16:814-24. 2010
  6. ncbi SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing
    Jun Li
    Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 4304 CCGC, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0936, USA
    Neoplasia 7:312-23. 2005
  7. ncbi Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide
    Min Zheng
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 4424B MS I, 1301 Catherine Street, Ann Arbor, MI 48109 5637, USA
    Anticancer Res 30:3321-31. 2010
  8. ncbi SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation
    Qingyang Gu
    Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
    Cancer Res 67:3616-25. 2007
  9. ncbi A small molecule that disrupts Mdm2-p53 binding activates p53, induces apoptosis and sensitizes lung cancer cells to chemotherapy
    Steven H Sun
    Division of Cancer Biology, Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109, USA
    Cancer Biol Ther 7:845-52. 2008
  10. ncbi Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis
    Dong Yang
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, 4424B Medical Science I, 1301 Catherine Street, Ann Arbor, MI 48109 5637, USA
    Breast Cancer Res Treat 133:189-99. 2012

Collaborators

  • Shaomeng Wang
  • Lijun Jia
  • Min Zheng
  • Hua Li
  • Jie Yang
  • Qingyang Gu
  • Jun Li
  • Yuan Zhu
  • Zhen Wang
  • Thomas L Saunders
  • Shannon W Davis
  • Jian Zhang
  • Ling Li
  • Hui Zhang
  • Rajal B Shah
  • Xiao Xu
  • Liang Xu
  • Menghang Xia
  • Stefan Rose-John
  • Min Wu
  • Mingjia Tan
  • Yongchao Zhao
  • Hongbin He
  • Sanjeev Shangary
  • Deepika Pamarthy
  • Dong Yang
  • Dongping Wei
  • Yuanhui Huang
  • Manju Swaroop
  • Yuli Wang
  • Ken Yasukawa
  • Max B Kelz
  • Su Qiu
  • Rebecca S Miller
  • Ke Ding
  • Donna McEachern
  • Zaneta Nikolovska-Coleska
  • Jianfeng Lu
  • Steven H Sun
  • Dajun Yang
  • Theodore S Lawrence
  • Jianyong Chen
  • Chuanlong Zhu
  • Katrina M Bockbrader
  • De Yun Feng
  • Qingnan Li
  • Ragini Vittal
  • Björn Schuster
  • Megan Robinson
  • Feng-Peng Huang
  • Ralph Graichen
  • Peter R Mertens
  • Jonathan T Sebolt
  • Amy Y Li
  • Peter G Smith
  • Gongxian Wang
  • Meredith A Morgan
  • Lili Zhao
  • Jie Yu
  • Xiufang Xiong
  • Sun Jung Kim
  • Margaret Liu
  • Jordan Kovacev
  • Douglas R Spitz
  • Zhen Qiang Pan
  • Jeanne A Stuckey
  • Meilan Liu
  • Shelley Dixon
  • Denzil Bernard
  • Haiying Sun
  • Xiaolan Ling
  • Jennifer L Meagher
  • Longchuan Bai
  • Shigeyasu Motohashi
  • Sigrid C Veasey
  • Daniel Normolle
  • Ming Guo
  • Masashi Yanagisawa
  • Sanmao Kang
  • Kenneth J Pienta
  • Susumu Kitanaka
  • Hiromasa Funato
  • Jason T Moore
  • Han Yi
  • Guoping Wang
  • Yipin Lu
  • Naoyuki Tomizawa
  • Qing Cheng Meng
  • Motofumi Miura
  • Dongguang Qin

Detail Information

Publications54

  1. ncbi SAG/ROC/Rbx/Hrt, a zinc RING finger gene family: molecular cloning, biochemical properties, and biological functions
    Y Sun
    Cancer Molecular Sciences, Pfizer Global Research and Development, Ann Arbor Laboratories, MI 48105, USA
    Antioxid Redox Signal 3:635-50. 2001
    ..Blocking SAG expression via antisense transfection inhibits tumor cell growth. Thus, SAG appears to be a valid drug target for anticancer therapy...
  2. ncbi Seeing is believing: visualization of transcriptional activity of p53
    Yi Sun
    Cancer Molecular Sciences, Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48105, USA
    Cancer Biol Ther 2:203-5. 2003
  3. ncbi Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor
    Dongping Wei
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109, USA
    Cancer Res 72:282-93. 2012
    ..Our findings offer proof-of-concept for use of MLN4924 as a novel class of radiosensitizer for the treatment of pancreatic cancer...
  4. ncbi Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases
    Jie Yang
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA
    Mol Cancer Ther 10:658-69. 2011
    ..Thus, SM-164 is a potent radiosensitizer via a mechanism involving caspase activation and holds promise for future clinical development as a novel class of radiosensitizer for the treatment of a subset of head and neck cancer patients...
  5. ncbi Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target
    Lijun Jia
    Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA
    Clin Cancer Res 16:814-24. 2010
    ..To investigate whether SAG serves as an anticancer target, we determined the effect of SAG silencing on cell proliferation, survival, and radiosensitivity...
  6. ncbi SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing
    Jun Li
    Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 4304 CCGC, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0936, USA
    Neoplasia 7:312-23. 2005
    ..Thus, SAK repression by p53 is likely mediated through the recruitment of HDAC repressors, and SAK repression contributes to p53-induced apoptosis...
  7. ncbi Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide
    Min Zheng
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 4424B MS I, 1301 Catherine Street, Ann Arbor, MI 48109 5637, USA
    Anticancer Res 30:3321-31. 2010
    ..In combination, MI-219-induced cytotoxicity was not affected by MDM2 knockdown nor by a XIAP inhibitor, but MI-219 sensitized cancer cells to etoposide, suggesting MI-219 could serve as a chemosensitizing agent...
  8. ncbi SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation
    Qingyang Gu
    Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
    Cancer Res 67:3616-25. 2007
    ..41 preneoplastic model. Thus, AP-1/SAG establishes an autofeedback loop, in which on induction by AP-1, SAG promotes c-Jun ubiquitination and degradation, thus inhibiting tumor-promoting activity of AP-1...
  9. ncbi A small molecule that disrupts Mdm2-p53 binding activates p53, induces apoptosis and sensitizes lung cancer cells to chemotherapy
    Steven H Sun
    Division of Cancer Biology, Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109, USA
    Cancer Biol Ther 7:845-52. 2008
    ..Thus, MI-43 or its analogues could be further developed as a novel class of anticancer drug for lung cancer cells harboring wt p53 as a single agent or in combination with chemo-drugs...
  10. ncbi Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis
    Dong Yang
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, 4424B Medical Science I, 1301 Catherine Street, Ann Arbor, MI 48109 5637, USA
    Breast Cancer Res Treat 133:189-99. 2012
    ..Our study demonstrates that IAPs are valid radiosensitizing targets in breast cancer cells and SM-164 could be further developed as a novel class of radiosensitizers for the treatment of radioresistant breast cancer...
  11. ncbi SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB
    Qingyang Gu
    Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA
    J Cell Biol 178:1009-23. 2007
    ....
  12. ncbi SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection
    Mingjia Tan
    Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0936, USA
    Neoplasia 8:1042-54. 2006
    ..Thus, pro-caspase-3 appears to be a substrate of SAG/ROC-SCF(beta-TrCP) E3 Ub ligase, which protects cells from apoptosis through increased apoptosis threshold by reducing the basal level of pro-caspase-3...
  13. ncbi Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2
    Min Zheng
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 5637, USA
    Cancer Res 68:7570-8. 2008
    ..Our studies suggest that TRAF2 is an attractive drug target for anticancer therapy and radiosensitization...
  14. ncbi SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation
    Mingjia Tan
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA
    Dev Cell 21:1062-76. 2011
    ..Collectively, our study identifies NF1 as a physiological substrate of SAG-CUL1-FBXW7 E3 ligase and establishes a ubiquitin-dependent regulatory mechanism for the NF1-RAS pathway during embryogenesis...
  15. ncbi SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP
    Jianfeng Lu
    University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
    Cancer Res 68:9384-93. 2008
    ..Furthermore, our data provide evidence that SM-164 is a promising new anticancer drug for further evaluation and development...
  16. ncbi Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression
    Lijun Jia
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, 4424B Medical Science I, Ann Arbor, MI 48109, USA
    Neoplasia 13:561-9. 2011
    ..Our study reveals a novel mechanism of MLN4924 action and showed that MLN4924 could be further developed as an effective anticancer agent by inducing apoptosis and irreversible senescence...
  17. ncbi ROC1/RBX1 E3 ubiquitin ligase silencing suppresses tumor cell growth via sequential induction of G2-M arrest, apoptosis, and senescence
    Lijun Jia
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA
    Cancer Res 69:4974-82. 2009
    ..Thus, ROC1 silencing triggers multiple death and growth arrest pathways to effectively suppress tumor cell growth, suggesting that ROC1 may serve as a potential anticancer target...
  18. ncbi CK2 phosphorylation of SAG at Thr10 regulates SAG stability, but not its E3 ligase activity
    Hongbin He
    Division of Cancer Biology, Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 4304 CCGC, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0936, USA
    Mol Cell Biochem 295:179-88. 2007
    ..These studies suggested that CK2 might regulate SAG-SCF E3 ligase activity through modulating SAG's stability, rather than its enzymatic activity directly...
  19. ncbi Disruption of Sag/Rbx2/Roc2 induces radiosensitization by increasing ROS levels and blocking NF-kappaB activation in mouse embryonic stem cells
    Mingjia Tan
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA
    Free Radic Biol Med 49:976-83. 2010
    ....
  20. ncbi SAG/ROC2/RBX2 E3 ligase promotes UVB-induced skin hyperplasia, but not skin tumors, by simultaneously targeting c-Jun/AP-1 and p27
    Hongbin He
    Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
    Carcinogenesis 29:858-65. 2008
    ..Thus, by simultaneously targeting c-Jun and p27, SAG accelerates UVB-induced skin hyperplasia, but not carcinogenesis...
  21. ncbi p27 degradation by an ellipticinium series of compound via ubiquitin-proteasome pathway
    Deepika Pamarthy
    Division of Cancer Biology, Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 0936, USA
    Cancer Biol Ther 6:360-6. 2007
    ..The finding could provide a new tool to further understand the mechanism of p27 degradation...
  22. ncbi Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition
    Zhen Wang
    Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, 48109, USA
    Cancer Res 69:6556-64. 2009
    ..The drugs may be useful in the treatment of human cancers with a gain-of-function p53 mutation...
  23. ncbi RBX1 (RING box protein 1) E3 ubiquitin ligase is required for genomic integrity by modulating DNA replication licensing proteins
    Lijun Jia
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Biol Chem 286:3379-86. 2011
    ..RBX-1 silencing also induces lethality during development of embryos and in adulthood. Thus, RBX1 E3 ligase is essential for the maintenance of mammalian genome integrity and the proper development and viability in C. elegans...
  24. ncbi CUL4B ubiquitin ligase in mouse development: a model for human X-linked mental retardation syndrome?
    Yongchao Zhao
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, 4424B MS 1, 1301 Catherine Street, Ann Arbor, MI 48109, USA
    Cell Res 22:1224-6. 2012
    ..Viable Cul4b-null mice provide the first animal model to study neuronal and behavioral deficiencies seen in human CUL4B XLMR patients...
  25. ncbi DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagy
    Yongchao Zhao
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA
    Mol Cell 44:304-16. 2011
    ..Furthermore, DEPTOR accumulates upon glucose deprivation and mTOR inhibition to induce autophagy. Thus, βTrCP-DEPTOR-mTOR intertwine to regulate cell survival and autophagy...
  26. ncbi Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth
    Manju Swaroop
    Cancer Molecular Sciences, Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, MI 48105, USA
    Anticancer Res 23:3167-74. 2003
    ..Thus, ligase dead mutants of Mdm2 did not act in a dominant negative manner to reactivate p53 and they are not oncogenes in MCF10A cells...
  27. ncbi Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
    Sanjeev Shangary
    Comprehensive Cancer Center and Department of Internal Medicine, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
    Proc Natl Acad Sci U S A 105:3933-8. 2008
    ..MI-219 activates p53 in normal tissues with minimal p53 accumulation and is not toxic to animals. MI-219 warrants clinical investigation as a new agent for cancer treatment...
  28. ncbi RBX1/ROC1 disruption results in early embryonic lethality due to proliferation failure, partially rescued by simultaneous loss of p27
    Mingjia Tan
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 4424B MS I, 1301 Catherine Street, Ann Arbor, MI 48109 5936, USA
    Proc Natl Acad Sci U S A 106:6203-8. 2009
    ..Our study demonstrates that the in vivo physiological function of RBX1 is to ensure cell proliferation by preventing p27 accumulation during the early stage of embryonic development...
  29. ncbi Identification and characterization of two splicing variants of human Noxa
    Zhen Wang
    Division of Cancer Biology, Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
    Anticancer Res 28:1667-74. 2008
    ..Unlike Noxa, BH3-less variants failed to potentiate apoptosis induced by etoposide. Thus, Noxa variants are unlikely to play a role in apoptosis regulation...
  30. ncbi E3 ubiquitin ligases as cancer targets and biomarkers
    Yi Sun
    Division of Cancer Biology, Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109 0936, USA
    Neoplasia 8:645-54. 2006
    ..This would eventually lead to the development of a novel class of anticancer drugs targeting specific E3 ubiquitin ligases, as well as the development of sensitive biomarkers for cancer treatment, diagnosis, and prognosis...
  31. ncbi AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression
    Jun Li
    Cancer Molecular Sciences, Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, MI 48105, USA
    Carcinogenesis 24:827-34. 2003
    ..In both lines, forced AMPK-beta1 expression inhibits tumor cell growth, suggesting that AMPK-beta1 induction may facilitate stress-induced growth inhibition and cell killing...
  32. ncbi A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells
    Katrina M Bockbrader
    Department of Radiation Oncology, Division of Cancer Biology, University of Michigan Comprehensive Cancer Center, 4304 CCGC, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0936, USA
    Oncogene 24:7381-8. 2005
    ..Thus, in these cell lines, Smac-mimic acts in an apparent IAPs dependent manner to induce apoptosis alone as well as sensitizes breast cancer cells to TRAIL or etoposide induced apoptosis via caspase-3 activation...
  33. ncbi Early NFkappaB activation is inhibited during focal cerebral ischemia in interleukin-1beta-converting enzyme deficient mice
    Feng-Peng Huang
    Department of Surgery (Neurosurgery, University of Michigan, Ann Arbor, USA
    J Neurosci Res 73:698-707. 2003
    ..Because cerebral ischemia induced infarction is significantly reduced in ICE KO mice, we conclude that early NFkappaB phosphorylation plays a disruptive role in the ischemic process...
  34. ncbi Targeting the mTOR-DEPTOR pathway by CRL E3 ubiquitin ligases: therapeutic application
    Yongchao Zhao
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA
    Neoplasia 14:360-7. 2012
    ....
  35. ncbi Targeting E3 ubiquitin ligases for cancer therapy
    Yi Sun
    Division of Cancer Biology, Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 0936, USA
    Cancer Biol Ther 2:623-9. 2003
    ..Emerging technologies, such as siRNA, will provide a better validation of many E3s. It is anticipated that E3 ubiquitin ligases will represent an important new target platform for future mechanism-driven drug discovery...
  36. ncbi Overview of approaches for screening for ubiquitin ligase inhibitors
    Yi Sun
    Division of Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA
    Methods Enzymol 399:654-63. 2005
    ..Experimental details for many of these assays can be found in other chapters in this volume...
  37. ncbi Chemosensitization by emodin, a plant-derived anti-cancer agent: mechanism of action
    Yi Sun
    Division of Cancer Biology, Department of Radiation Oncology, The University of Michigan, 4304 Cancer Center, 1500 E. Medical Center Dr, Ann Arbor, MI 48109, USA
    Cancer Biol Ther 7:476-8. 2008
  38. ncbi p53 and its downstream proteins as molecular targets of cancer
    Yi Sun
    Division of Cancer Biology, Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109-0936, USA
    Mol Carcinog 45:409-15. 2006
    ..If a therapeutic window is obtained, a SAK inhibitor identified from high throughput screening (HTS) could serve as a lead compound for development of a novel class of apoptosis-inducing anticancer drugs...
  39. ncbi Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase
    Yi Sun
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, 4424B Medical Science I, 1301 Catherine Street, Ann Arbor, MI 48109, USA
    Protein Cell 4:103-16. 2013
    ..Given its major role in promoting targeted degradation of tumor suppressive proteins, leading to apoptosis suppression and accelerated tumorigenesis, SAG E3 ligase appears to be an attractive anticancer target...
  40. ncbi Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis
    Yuanhui Huang
    Cancer Molecular Sciences, Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, MI 48105, USA
    Cancer Res 62:2913-22. 2002
    ..Induction of TNFR1, TNFSF7, and caspase-8 were confirmed by Northern and Western analyses. Thus, activation of tumor necrosis factor death receptor pathway appears to be associated with HDAC5-induced spontaneous apoptosis...
  41. ncbi RASSF1A, a critical gene inactivated during nasopharyngeal carcinogenesis?
    Yi Sun
    Division of Cancer Biology, Department of Radiation Oncology, The University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109, USA
    Cancer Biol Ther 4:1123-4. 2005
  42. ncbi Insulin-like growth factor receptor-1 as an anti-cancer target: blocking transformation and inducing apoptosis
    Yuli Wang
    Cancer Molecular Sciences, Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, MI 48105, USA
    Curr Cancer Drug Targets 2:191-207. 2002
    ..Cancer patients could eventually benefit from the development of these specific IGF-IR antagonists...
  43. ncbi Autocrine human growth hormone inhibits placental transforming growth factor-beta gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells
    Ralph Graichen
    Institute of Molecular and Cell Biology, 30 Medical Drive, Singapore 117609, Republic of Singapore
    J Biol Chem 277:26662-72. 2002
    ..Such transcriptional repression of negative regulatory factors, such as PTGF-beta, may also be requisite for direct stimulation of mammary carcinoma cell mitogenesis by hGH...
  44. ncbi Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice
    Chuanlong Zhu
    Laboratory of Infectious Immunology, Department of Infectious Disease, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
    Hum Gene Ther 17:589-600. 2006
    ....
  45. ncbi Global genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinoma cells
    Megan Robinson
    Departments of Molecular Sciences and Technologies Pfizer Global Research and Development Ann Arbor Laboratories Ann Arbor, Michigan USA
    Cancer Biol Ther 2:406-15. 2003
    ..Further characterization of these genes will lead to a better understanding of the mechanism of p53 action and p53 regulation of other signaling pathways. It will also provide novel cancer drug targets for further validation...
  46. ncbi HIV-1 Tat depresses DNA-PK(CS) expression and DNA repair, and sensitizes cells to ionizing radiation
    Yi Sun
    Department of Radiation Toxicology and Oncology, Beijing Institute of Radiation Medicine, Beijing, People s Republic of China
    Int J Radiat Oncol Biol Phys 65:842-50. 2006
    ..Here we explored the effects of the HIV-1 Tat protein on cellular responses to ionizing radiation...
  47. ncbi Gene expression changes induced by green tea polyphenol (-)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray
    Ragini Vittal
    Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, State University of New Jersey, 164 Frelinghuysen Road, Piscataway, NJ 08854, USA
    Mol Cancer Ther 3:1091-9. 2004
    ..The elucidation of gene expression changes between H2O2-dependent and H2O2-independent responses helps us better understand the cancer chemopreventive and anticancer actions of EGCG...
  48. ncbi Combinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells
    Peter R Mertens
    Department of Nephrology and Immunology, Medical Clinic II, RWTH Aachen, Pauwelsstrasse 30, Germany
    J Biol Chem 277:24875-82. 2002
    ....
  49. ncbi An essential role for orexins in emergence from general anesthesia
    Max B Kelz
    Department of Anesthesiology and Critical Care, Mahoney Institute for Neurological Sciences, Center for Sleep and Respiratory Neurobiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    Proc Natl Acad Sci U S A 105:1309-14. 2008
    ..These findings support the concept that emergence depends, in part, on recruitment and stabilization of wake-active regions of brain...
  50. ncbi Effect of hepatitis C virus nonstructural protein NS3 on proliferation and MAPK phosphorylation of normal hepatocyte line
    De Yun Feng
    Department of Pathology, College of Basic Medicine, Central South University, Changsha 410078, Hunan Province, China
    World J Gastroenterol 11:2157-61. 2005
    ..To study the effect of hepatitis C virus nonstructural region 3 (HCV NS3) protein on proliferation and transformation of normal human liver cell line...
  51. ncbi Possible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclasts
    Yi Sun
    Department of Anatomy, Institute of Biomedicine, University of Turku, Finland
    J Biol Chem 280:32356-61. 2005
    ....
  52. ncbi Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF
    Björn Schuster
    Biochemisches Institut, Christian Albrechts Universitat zu Kiel, Olshausenstr 40, D 24098 Kiel, Germany
    J Biol Chem 278:9528-35. 2003
    ..Engineering a CNTFR-specific human CNTF variant may therefore be a prerequisite to improving the safety profile of CNTF...
  53. ncbi Smad4 inhibits tumor growth by inducing apoptosis in estrogen receptor-alpha-positive breast cancer cells
    Qingnan Li
    Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35294 0019, USA
    J Biol Chem 280:27022-8. 2005
    ..Smad4-induced apoptosis in ERalpha-positive breast cancer cells may explain the invasive nature of ERalpha-negative breast tumors, thereby providing a potential target for breast cancer intervention...
  54. ncbi Inhibitory effect of the rhizomes of Alpinia officinarum on TPA-induced inflammation and tumor promotion in two-stage carcinogenesis in mouse skin
    Ken Yasukawa
    Nat Med (Tokyo) 62:374-8. 2008
    ..These compounds (1-7) tested showed marked anti-inflammatory effects, with a 50% inhibitory dose of 0.8-2.7 micromol/ear...